These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

32 related articles for article (PubMed ID: 11179833)

  • 1. Mutation analysis underlying the downregulation of the thyroid hormone receptor β1 gene in the Chinese breast cancer population.
    Ling Y; Ling X; Fan L; Wang Y; Li Q
    Onco Targets Ther; 2015; 8():2967-72. PubMed ID: 26527882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BRCA1 and MDM2 as independent blood-based biomarkers of head and neck cancer.
    Bhowmik A; Das S; Bhattacharjee A; Choudhury B; Naiding M; Ghosh SK; Choudhury Y
    Tumour Biol; 2016 Oct; ():. PubMed ID: 27714671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TP53 in bone and soft tissue sarcomas.
    Thoenen E; Curl A; Iwakuma T
    Pharmacol Ther; 2019 Oct; 202():149-164. PubMed ID: 31276706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The oncoprotein HBXIP modulates the feedback loop of MDM2/p53 to enhance the growth of breast cancer.
    Li H; Liu Q; Wang Z; Fang R; Shen Y; Cai X; Gao Y; Li Y; Zhang X; Ye L
    J Biol Chem; 2015 Sep; 290(37):22649-61. PubMed ID: 26229107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical efficacy of vorinostat in a patient with leiomyosarcoma.
    Lee J; McGuire C
    Clin Med Insights Oncol; 2012; 6():101-5. PubMed ID: 22408374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the p53 Pathway in Ewing Sarcoma.
    Neilsen PM; Pishas KI; Callen DF; Thomas DM
    Sarcoma; 2011; 2011():746939. PubMed ID: 21197471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The E-cadherin repressor slug and progression of human extrahepatic hilar cholangiocarcinoma.
    Zhang KJ; Wang DS; Zhang SY; Jiao XL; Li CW; Wang XS; Yu QC; Cui HN
    J Exp Clin Cancer Res; 2010 Jul; 29(1):88. PubMed ID: 20594328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mechanisms of uterine leiomyosarcomas: involvement of defect in LMP2 expression.
    Hayashi T; Shimamura Y; Saegusa T; Horiuchi A; Kobayashi Y; Hiraoka N; Kanai Y; Aburatani H; Sano K; Konishi I
    Gene Regul Syst Bio; 2008 Jul; 2():297-305. PubMed ID: 19787091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53-independent mechanisms regulate the P2-MDM2 promoter in adult astrocytic tumours.
    Dimitriadi M; Poulogiannis G; Liu L; Bäcklund LM; Pearson DM; Ichimura K; Collins VP
    Br J Cancer; 2008 Oct; 99(7):1144-52. PubMed ID: 18781178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The MDM2 promoter polymorphism SNP309T-->G and the risk of uterine leiomyosarcoma, colorectal cancer, and squamous cell carcinoma of the head and neck.
    Alhopuro P; Ylisaukko-Oja SK; Koskinen WJ; Bono P; Arola J; Järvinen HJ; Mecklin JP; Atula T; Kontio R; Mäkitie AA; Suominen S; Leivo I; Vahteristo P; Aaltonen LM; Aaltonen LA
    J Med Genet; 2005 Sep; 42(9):694-8. PubMed ID: 16141004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormalities of the P53, MDM2, BCL2 and BAX genes in acute leukemias.
    Wojcik I; Szybka M; Golanska E; Rieske P; Blonski JZ; Robak T; Bartkowiak J
    Neoplasma; 2005; 52(4):318-24. PubMed ID: 16059649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extrapleural solitary fibrous tumor: clinicopathologic study of 17 cases and molecular analysis of the p53 pathway.
    Morimitsu Y; Nakajima M; Hisaoka M; Hashimoto H
    APMIS; 2000 Sep; 108(9):617-25. PubMed ID: 11110050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 gene mutation and MDM2 overexpression in a case of primary malignant fibrous histiocytoma of the jejunum.
    Jiao YF; Nakamura S; Sugai T; Habano W; Uesugi N; Oikawa M; Sato T
    APMIS; 2002 Feb; 110(2):165-71. PubMed ID: 12064872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relative quantitation of p53 and MDM2 gene expression in leiomyosarcoma; real-time semi-quantitative reverse transcription-polymerase chain reaction.
    Miyajima K; Tamiya S; Oda Y; Adachi T; Konomoto T; Toyoshiba H; Masuda K; Tsuneyoshi M
    Cancer Lett; 2001 Mar; 164(2):177-88. PubMed ID: 11179833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormalities of the p53 MDM2 and DCC genes in human leiomyosarcomas.
    Patterson H; Gill S; Fisher C; Law MG; Jayatilake H; Fletcher CD; Thomas M; Grimer R; Gusterson BA; Cooper CS
    Br J Cancer; 1994 Jun; 69(6):1052-8. PubMed ID: 8198970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative study of P53/MDM2 genes alterations and P53/MDM2 proteins immunoreactivity in soft-tissue sarcomas.
    Rieske P; Bartkowiak JK; Szadowska AM; Olborski B; Harezga-Bal B; Debiec-Rychter M
    J Exp Clin Cancer Res; 1999 Sep; 18(3):403-16. PubMed ID: 10606188
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.